JCS/T2D JCS/T2D
JCS/T2D JCS/T2D
  • Home
  • About
  • Disclaimer
  • Privacy

JCS/T2D - We are advocates. We learn. We share. We inform.

Details
By J. Smith
J. Smith
Articles
22 May 2023
Last Updated: 01 March 2024
Hits: 289
  • Diabetes
  • Vision Care

Diabetes and Eye Health

Individuals diagnosed with diabetes are at a significantly higher risk of developing eye conditions that can lead to vision loss. In fact, people with diabetes are 25 times more likely to experience blindness compared to those without the condition. Diabetic retinopathy, a leading cause of blindness in adults of working age, along with other eye disorders such as glaucoma and cataracts, tend to occur more frequently and at an earlier age in those with diabetes.

The Importance of Regular Eye Exams

To safeguard against diabetes-related vision loss, it is crucial for those with diabetes to undergo a comprehensive dilated eye exam annually. This type of exam is vital because many eye problems do not present obvious symptoms in the early stages and can only be detected through a thorough examination. For individuals with type 1 diabetes, it is recommended to have this exam within five years of diagnosis and annually thereafter. Those with type 2 diabetes should have a dilated exam soon after diagnosis due to the possibility of having lived with undiagnosed diabetes for years, which could have put their eyes at risk.

Managing Diabetes: The ABCs

The ABCs of diabetes—A1c, Blood pressure, and Cholesterol—are key factors in managing diabetes and reducing the risk of complications:

  • A1c: This blood test reflects the average blood sugar levels over the past three months. The goal for many is to maintain an A1c level below 7%, although individual goals may vary based on a doctor's recommendations.
  • Blood Pressure: High blood pressure can lead to heart disease. The target for most people with diabetes is below 130/80 mmHg, but it's important to consult with a healthcare provider for a personalized goal.
  • Cholesterol: LDL cholesterol, often referred to as "bad" cholesterol, can cause blood vessels to clog. Conversely, HDL cholesterol, the "good" kind, helps remove LDL from the blood vessels. Goals for LDL cholesterol levels are typically less than 100 mg/dL for those without cardiovascular disease, less than 70 mg/dL for those with at least one risk factor for cardiovascular disease, and less than 55 mg/dL for those with established cardiovascular disease.

Additional Tips for Diabetes Management

  • Smoking: Smoking is known to be a cause of type 2 diabetes and makes managing the condition more challenging. Quitting smoking is strongly advised to reduce the risk of diabetes-related health issues.
  • UV Protection: When outdoors, wearing sunglasses that block ultraviolet rays is recommended to protect the eyes.

When to Contact Your Eye Doctor

Any changes in vision, such as blurriness, spots, redness, or pain, should prompt immediate contact with an eye doctor. Early detection and treatment are key to preventing serious vision loss.

Managing diabetes effectively involves regular monitoring of blood sugar, blood pressure, and cholesterol levels, as well as maintaining a healthy lifestyle. Regular dilated eye exams are essential for early detection of eye problems, which is critical in preventing diabetes-related vision loss.

Frequently Asked Questions

What are the specific symptoms of diabetic retinopathy to watch out for?
Early stages may not have symptoms, but as it progresses, signs can include blurred vision, floaters, dark areas of vision, and difficulty perceiving colors. Regular eye exams are crucial for early detection.

How does the management of diabetes differ between Type 1 and Type 2 in the context of preventing eye diseases?
Both types require careful monitoring of blood sugar, blood pressure, and cholesterol. Type 1 diabetes management typically involves insulin therapy, while Type 2 may involve lifestyle changes, oral medications, and possibly insulin.

Are there any specific dietary recommendations or supplements that can support eye health in people with diabetes?
A diet rich in green leafy vegetables, omega-3 fatty acids (found in fish), and vitamins C and E can support eye health. Supplements like lutein and zeaxanthin may also be beneficial, but it's important to consult with a healthcare provider before starting any supplements.

Details
By J. Smith
J. Smith
Articles
10 May 2023
Last Updated: 01 March 2024
Hits: 243
  • Diabetes
  • Blood Glucose Monitor
  • OneTouch
  • Verio

Tips for Using a OneTouch Verio Flex Meter

The OneTouch Verio Flex is a Bluetooth-enabled device designed to help manage diabetes by monitoring blood glucose levels. This device syncs with the OneTouch Reveal app, available for both Apple and Android phones, to provide a comprehensive overview of your blood glucose data.

When you receive your OneTouch Verio Flex meter, a healthcare professional will likely assist you with the initial setup and provide some training to ensure you understand how to use the device effectively. The kit typically includes the meter itself, a lancing device, sterile lancets, a carrying case, and an owner’s manual.

To make the most of your device, it's recommended that you install the OneTouch Reveal app on your smartphone. This app will allow you to sync your meter, ensuring it displays the correct date, time, and time zone. The OneTouch website provides detailed instructions on how to set up your meter to sync with the OneTouch Reveal mobile and web apps.

Here are some general tips to ensure accurate readings:

  1. Before using your meter to take a reading, sync it with your OneTouch Reveal app and verify that it's displaying the correct date and time. This should be done regularly, especially when there's a seasonal time change or if you travel to another time zone.
  2. When the clock goes ahead or back an hour due to daylight saving time changes, force a sync to ensure the meter is showing the correct date and time before taking a reading.
  3. If you travel to another time zone, force a sync to adjust the meter to the new time zone. Again, make sure the meter shows the correct date and time before taking a reading.

The OneTouch Reveal app not only helps in managing your blood glucose levels but also provides personalized summaries of your blood sugar, visually presents data, and helps uncover patterns that might be missed otherwise. The app also allows you to share your progress with your healthcare team, making it a valuable tool for managing diabetes. 

Remember, accurate blood glucose monitoring is crucial in managing diabetes effectively. Always ensure your device is correctly synced and displays the right date and time before taking a reading.

Frequently Asked Questions

How much does the OneTouch Verio Flex meter cost, and where can it be purchased? Are there any insurance or rebate options available to help with the cost?
The price of the OneTouch Verio Flex meter may vary depending on the retailer and location. It's commonly available at pharmacies, online stores, and through medical supply vendors. Insurance coverage for diabetes monitoring equipment differs, so it's advisable to consult with your insurance provider.

How does the OneTouch Verio Flex compare to other glucose meters available on the market in terms of accuracy, ease of use, and features?
The OneTouch Verio Flex is known for its simplicity, Bluetooth connectivity for syncing readings with a mobile app, and clear display. Comparatively, some meters may offer additional features like more extensive data storage or different connectivity options. Accuracy, ease of use, and specific features should guide the choice.

What are the common issues or error messages that users might encounter with the OneTouch Verio Flex meter, and how can they be resolved?
Common issues may include error messages due to improper insertion of test strips or inadequate blood samples. The manufacturer's guide and customer support can offer solutions to these problems, including how to correctly use the meter and troubleshoot operational issues.

OneTouch Verio Flex

  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23

Page 23 of 23

Articles

  • Professor Juleen R. Zierath: Three Decades of Showing How Exercise Changes Metabolism
  • A More Human View of Glucose: How Hourly Visualizations Reduce Anxiety and Reveal Real Patterns
  • Wegovy Will Not Go OTC: What the Sources Actually Say
  • Bridging Data and Healthcare in the Nordics
  • How Well Do My CGM and BGM Readings Match?
  • Epigenetic Clues to Heart Risk in Type 2 Diabetes
  • Could a Gut Bacterium Help Transform Diabetes and Obesity Care?
  • Why mRNAs Are a Good Option for Vaccines
  • Why I Took Medical Courses to Strengthen My Data Skills
  • New Research Reveals the Hidden Complexity of Insulin Resistance
  • What the 2025 Diabetes Care Updates Mean for You
  • How an Hour-by-Hour View Transforms Time in Range Insights
  • Successfully Completed: Diabetes – A Global Challenge
  • Join the 5K@ADA Virtual Challenge to Promote Diabetes Awareness and Healthy Living
  • How Tirzepatide is Revolutionizing Type 2 Diabetes Prevention in Overweight and Obese Adults
  • Eli Lilly and Novo Nordisk Invest in Increased Manufacturing Capacity for GLP-1 Drugs
  • FDA Issues Alert on Compounded Semaglutide Dosing Errors
  • Join the 5K@EASD Virtual Challenge to Promote Diabetes Awareness and Healthy Living
  • Regulatory Hurdles for Awiqli: Approval in Canada and EU, Concerns in the US
  • Tirzepatide’s Efficacy in Treating Obstructive Sleep Apnea

News

January 2026

  • Wegovy Oral Pill Launches in United States

December 2025

  • FDA Approves First Oral GLP-1 for Chronic Weight Management
  • Retatrutide Delivers Phase 3 Success and Signals Lilly’s Strategic Positioning

November 2025

  • Novo Nordisk Seeks FDA Approval for Higher 7.2 mg Dose of Wegovy
  • Novo Nordisk Reports Strong Phase 2 Results for Amycretin in Type 2 Diabetes
  • Oral Semaglutide Does Not Slow Alzheimer’s Progression: How Today’s Results Fit the Larger Story
  • Zealand Pharma Pauses Development of Dapiglutide

October 2025

  • Innovent’s Mazdutide Outperforms Semaglutide in Head-to-Head Trial
  • Semaglutide’s Heart Benefits Extend Beyond Weight Loss
  • Terns Ends Development of Oral Obesity Drug After Phase 2 Results
  • FDA Approves Novo Nordisk’s Oral Semaglutide for Heart Protection in Type 2 Diabetes

Top Subjects

  • Type 2 Diabetes
  • Obesity Treatment
  • Semaglutide
  • Novo Nordisk
  • Wegovy
  • GLP-1
  • Eli Lilly
  • Tirzepatide
  • Continuous Glucose Monitoring
  • Oral Semaglutide
  • Clinical Trial Results
  • Ozempic
  • FDA Approval
  • Zepbound
  • GLP-1 Therapy
  • GLP-1 Medicines
  • Drug Regulation
  • Medication Safety
  • EVOKE Trials
  • Alzheimer’s Disease
  • Oral GLP-1 Therapy
  • Time in Range
  • Diabetes
  • Clinical Trials
  • Glucose Patterns
  • Diabetes Data Visualization
  • Emotional Impact of CGM
  • Obesity
  • Diabetes Management
  • Cardiovascular Health

Contact Us

Search

5K@ADA

5K@EASD

World Obesity Day

Rochen Web Hosting

Bluesky Social

  • You are here:  
  • Home
 
Copyright © 2026 JCS/T2D - A Diabetes Journey. All Rights Reserved.
Joomla! is Free Software released under the GNU General Public License.